Alpert Abby, Lakdawalla Darius, Sood Neeraj
University of Pennsylvania; 3641 Locust Walk, Colonial Penn Center, Philadelphia, PA 19104, United States.
NBER, National Bureau of Economic Research; 1050 Massachusetts Ave., Cambridge, MA 02138, United States.
J Public Econ. 2023 May;221. doi: 10.1016/j.jpubeco.2023.104860. Epub 2023 Mar 17.
This paper examines how direct-to-consumer advertising (DTCA) for prescription drugs influences utilization by exploiting a large and plausibly exogenous shock to DTCA driven by the introduction of Medicare Part D. Part D led to larger increases in advertising in geographic areas with higher concentrations of Medicare beneficiaries. We examine the impact of this differential increase in advertising on non-elderly individuals to isolate advertising effects from the direct effects of Part D. We find that exposure to advertising led to large increases in treatment initiation and improved medication adherence. Advertising also had sizeable positive spillover effects on non-advertised generic drugs. Our results imply significant spillovers from Medicare Part D on the under-65 population and an important role for non-price factors in influencing prescription drug utilization.
本文通过利用医疗保险D部分的引入所带来的大规模且看似外生的直接面向消费者的处方药广告(DTCA)冲击,研究了DTCA如何影响药物使用情况。D部分导致医疗保险受益人群集中度较高的地理区域的广告投放量有更大幅度的增长。我们研究了这种广告投放差异增加对非老年个体的影响,以将广告效应与D部分的直接效应区分开来。我们发现,接触广告导致治疗开始率大幅提高以及用药依从性改善。广告对未做广告的非专利药也产生了相当大的积极溢出效应。我们的结果表明医疗保险D部分对65岁以下人群有显著的溢出效应,并且非价格因素在影响处方药使用方面发挥着重要作用。